June 27, 2007 — REVA Medical, Inc. recently announced enrollment of the first patients in a first-in-man clinical trial designed to evaluate the safety of the REVA Bioresorbable Coronary Stent for the treatment of coronary artery disease.

The RESORB (REVA Endovascular Study of a Bioresorbable Coronary Stent) trial will enroll up to 30 patients at multiple sites in Germany and Brazil in a non-randomized study with an initial assessment of major adverse cardiac events (MACE) at 30 days and a follow-up period of five years.

June 29, 2007 - A potential sudden cardiac arrest prevented by an implantable cardioverter defibrillator (ICD) provides the first scientific evidence that someone may experience instantaneous death near the anniversary date of a past traumatic event, reports a study published in the July 2007 edition of HeartRhythm.

June 25, 2007 - A study published in a recent issue of The New England Journal of Medicine (NEJM) showed that younger menopausal women (aged 50-59) who received a standard dose of estrogen therapy had significantly less coronary artery calcification at the end of the study period compared with those taking placebo. Coronary artery calcification is a marker of plaque in the arteries and a predictor of future cardiovascular events.

June 22, 2007 — The government recently evaluated hospitals around the country on their performance in the treatment of patients suffering from heart attacks or heart failure.

Almost all 4,500 hospitals performed at the national average when it came to their patient mortality rates.

However, for heart failure, 38 hospitals were listed as performing better than the national rate for heart failure, and 35 were listed as performing worse. For heart attacks, 17 performed better; 7 worse. The ratings are based on hospital claims data filed from July 2005 to June 2006.